Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists
INTRODUCTIONInflammatory bowel disease (IBD) is the consequence of a sustained inflammatory response to commensal microorganisms in a genetically susceptible host with excessive production of pro-inflammatory cytokines. Recent evidence now suggests...








